ESC 365 - Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort

ESC2025 Premium Access

Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort

Session: Pathophysiology in acute coronary syndromes (1)

Topic: Biomarkers

Speaker: Doctor A. Oancea (Iasi, RO)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Alexandru Oancea

Grigore T. Popa University of Medicine and Pharmacy, Iasi (Romania)

0 follower

7 more presentations in this session

SMC-derived foam cells regulate atherosclerotic plaque stability via the crosstalk between ECM remodeling and WNT signaling

Speaker: Mx C. Li (Qingdao, CN)

High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome

Speaker: Ms S. Nilsson (Gothenburg, SE)

Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease

Speaker: Doctor F. Wenzl (Zurich, CH)

Cigarette smoking and release of the inflammatory chemokine CXCL10 (IP-10) after ST-elevation myocardial infarction

Speaker: Doctor L. Spray (Newcastle-Upon-Tyne, GB)

Hyperglycaemia-induced trained immunity alters monocyte function in type 2 diabetes patients after myocardial infarction

Speaker: Doctor T. Kufazvinei (Oxford, GB)

Access the full session

Pathophysiology in acute coronary syndromes (1)

Speakers: Doctor A. Oancea, Mx C. Li, Ms S. Nilsson, Doctor F. Wenzl, Doctor L. Spray...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources